KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Other Working Capital Changes (2017 - 2025)

Historic Other Working Capital Changes for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to -$59.0 million.

  • Elanco Animal Health's Other Working Capital Changes rose 7620.97% to -$59.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $208.0 million, marking a year-over-year increase of 13939.39%. This contributed to the annual value of -$11.0 million for FY2024, which is 20000.0% down from last year.
  • As of Q3 2025, Elanco Animal Health's Other Working Capital Changes stood at -$59.0 million, which was up 7620.97% from -$52.0 million recorded in Q2 2025.
  • Elanco Animal Health's 5-year Other Working Capital Changes high stood at $439.0 million for Q1 2023, and its period low was -$435.0 million during Q4 2023.
  • Its 5-year average for Other Working Capital Changes is $11.1 million, with a median of $7.0 million in 2021.
  • Per our database at Business Quant, Elanco Animal Health's Other Working Capital Changes soared by 173000.0% in 2021 and then plummeted by 280000.0% in 2023.
  • Quarter analysis of 5 years shows Elanco Animal Health's Other Working Capital Changes stood at -$268.0 million in 2021, then dropped by 2.99% to -$276.0 million in 2022, then tumbled by 57.61% to -$435.0 million in 2023, then surged by 118.85% to $82.0 million in 2024, then crashed by 171.95% to -$59.0 million in 2025.
  • Its last three reported values are -$59.0 million in Q3 2025, -$52.0 million for Q2 2025, and $237.0 million during Q1 2025.